Fiduciary Trust’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-16,033
Closed -$241K – 871
2025
Q4
$241K Hold
16,033
– – ﹤0.01% 788
2025
Q3
$231K Sell
16,033
-39,791
-71% -$565K ﹤0.01% 787
2025
Q2
$796K Hold
55,824
– – 0.01% 452
2025
Q1
$832K Buy
55,824
+31,922
+134% +$500K 0.01% 424
2024
Q4
$344K Buy
+23,902
New +$370K ﹤0.01% 545
2022
Q2
– Sell
-142,750
Closed -$2.86M – 631
2022
Q1
$2.86M Hold
142,750
– – 0.05% 211
2021
Q4
$3.62M Buy
+142,750
New +$3.69M 0.06% 188

Other funds holding BMEZ

Fiduciary Trust's BMEZ Position: Q1 2026 in Review

Fiduciary Trust sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2026, closing a stake of 16,033 shares — an estimated $241K sold.

Fiduciary Trust first reported a position in BMEZ in Q4 2021 and held it in 7 quarters. The position peaked at $3.62M in Q4 2021. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Fiduciary Trust reported no remaining BlackRock Health Sciences Trust II position as of Q1 2026 after selling out during the quarter.
  • Fiduciary Trust sold 16,033 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $241K.
  • Fiduciary Trust first reported a position in BlackRock Health Sciences Trust II in Q4 2021 and held it in 7 quarters.
  • Fiduciary Trust's BlackRock Health Sciences Trust II position peaked at $3.62M in Q4 2021.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.